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Patients experiencing natural infection with Borrelia burgdorferi display a spectrum
of associated symptoms and severity, strongly implicating the impact of genetically
determined host factors in the pathogenesis of Lyme disease. Herein, we provide a
summary of the host genetic factors that have been demonstrated to influence the
severity and chronicity of Lyme arthritis symptoms, and a review of the resources
available, current progress, and added value of a forward genetic approach for identification
of novel genetic regulators.
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INTRODUCTION TO LYME DISEASE
Lyme Disease, caused by infection with the tick borne spiro-
chete Borrelia burgdorferi, is a growing societal concern, espe-
cially in endemic regions of the United States and Europe.
Approximately 30,000 case reports are filed by physicians each
year in the United States (C.D.C, 2013a), while the CDC has
upwardly revised their best estimate of the total incidence to
300,000/year, based on several complementary lines of evidence
(Kuehn, 2013). Part of the societal concern is rooted in the
uncertainty surrounding pathological outcomes associated with
B. burgdorferi infection. A large percentage (70%) of infected
individuals develop the characteristic bulls-eye rash erythema
migrans at the site of the infected tick bite, with progression
to further clinical complications following dissemination of the
spirochete. Arthritis, the most common symptom occurs in
30–60% of infected individuals, while Bell’s palsy and other neu-
rological symptoms are seen in 10–12% of patients (Wormser
et al., 2006; C.D.C, 2013b). Carditis has been considered a
rare complication (<1%), however, 3 recent deaths with docu-
mented B. burgdorferi in autopsied heart tissue strongly argue for
increased vigilance in detecting infection of this tissue (C.D.C,
2013c).
The wide variation in Lyme disease symptoms and sever-
ity observed within the patient population is thought to reflect
unique features of individual B. burgdorferi isolates that influ-
ence invasive potential, as well as heritable factors in the patient
population that contribute to clinical severity. Furthermore,
although most patients resolve infection with appropriate antibi-
otic therapy, a small percentage of treated patients with severe
clinical symptoms fail to resolve and develop a chronic dis-
ease termed Post Treatment Lyme Disease (Steere and Glickstein,
2004). Thus, there are compelling reasons to identify host
genes that determine the severity of Lyme disease, both in
understanding the pathogenic mechanisms of acute clinical dis-
ease and in characterizing predisposing features for chronic
disease. This review will assess past and ongoing studies that
have provided insight into genetic susceptibility to Lyme arthri-
tis, with particular emphasis on studies using Forward Genetic
approaches.
WHAT IS FORWARD GENETICS?
Forward genetics is an unbiased genetic approach that begins with
a heritable trait of interest and attempts to determine the alle-
les responsible for the observed variability through a process of
genetic mapping. In contrast, reverse genetics is a hypothesis-
driven scientific approach that begins with a gene of interest
and attempts to determine the phenotypic impacts caused by
experimental manipulations of that gene. Classically, forward
genetic studies were first performed through random mutage-
nesis screens. More recently, forward genetics has been used to
map pre-existing genetic variations in human populations or
experimental animal models. In practice, forward genetic stud-
ies involve three key steps: (1) Each individual in a population
of mixed genetic composition is surveyed for the trait of inter-
est; (2) The genetic makeup of each individual is assessed; (3)
Statistical calculations predict the strength of association in the
study population between the measured trait and each genetic
locus in the genome. Forward genetic screens often produce a
map across the entire genome with peaks and valleys denoting
areas with strong or weak statistical association with the trait,
respectively.
Scientific investigations into heritable genetic risk factors
that contribute to complex disease have been conducted using
a variety of approaches, including Genome Wide Association
Studies (GWAS) and forward genetic screens in tractable animal
models.
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GENOMEWIDE ASSOCIATION STUDIES AS A
METHODOLOGY FOR STUDYING COMPLEX GENETIC TRAITS
IN HUMANS - SUCCESSES AND LIMITATIONS
GenomeWide Association Studies were first proposed in themid-
1990s as a way to study association between human genetic poly-
morphisms and complex, multigenic traits. Rather than measure
all genetic variation present in each individual, approximately one
million Single Nucleotide Polymorphisms (SNPs) are assayed as
genetic landmarks, and scored for association with the trait of
interest. Based on linkage disequilibrium, genes in close proximity
to associated SNP landmarks are potential candidates for further
investigation.
This technique is well-suited to identify susceptibility genes
that are of intermediate prevalence in the population, with aMean
Allele Frequency of greater than 0.05 (Risch and Merikangas,
1996). Although no such studies of Lyme arthritis severity have
been conducted, GWAS has been extensively used to investigate
genetic modulators of other inflammatory conditions including
rheumatoid arthritis (RA). Thus far, almost fifty susceptibility
loci have been identified for RA, accounting for approximately
one-half of the total genetic variation expected in populations of
European ancestry. Nineteen of these loci have been refined to a
single candidate gene association, and the underlying causal poly-
morphism has been predicted for seven of these loci (Eyre et al.,
2012).
Recent studies with RA and juvenile RA have involved cohorts
of up to 10,000 patients and controls, pointing out the require-
ment for large populations of well-characterized patients for
GWAS analysis (Hinks et al., 2013). If sufficiently large sample
sizes could be achieved, these findings suggest that GWAS could
be a successful strategy to investigate Lyme arthritis susceptibil-
ity loci, but also indicate that additional approaches are needed
to capture the significant fraction of variation likely to be left
unaccounted for.
It is also important to recognize that identification of regula-
tory loci is not the ultimate goal of a forward genetics study, but is
only a first step. While association of a specific genetic landmark
to disease susceptibility may have potential relevance to clinical
diagnosis, there is added value in the formal investigation of can-
didate genes and predicted causal polymorphisms, and in further
understanding the underlying mechanisms of pathogenesis. This
type of mechanistic investigation frequently involves the use of
animal models.
USE OF ANIMAL MODELS FOR IDENTIFICATION OF GENES
REGULATING DISEASE SEVERITY
Animal models provide an alternative approach for identification
of genes that regulate disease development. Inbred mouse lines
are powerful genetic resources, which have been widely used to
identify genes associated with disease severity. Visionary scientists
began the breeding of inbred mice over a century ago. Each mod-
ern inbred line has fixed genetic composition, while the plentitude
of inbred strains collectively capture a large amount of genetic
variation. Several advances in the past decade have significantly
added to their value, particularly the publication of the mouse
genome, coupled with various efforts to define the genetic vari-
ation between inbred mouse strains (Gregory et al., 2002; Keane
et al., 2011). More recently, the Collaborative Cross was devel-
oped, which represents an ambitious community effort by mouse
geneticists to develop approximately 1000 additional recombi-
nant inbred mouse strains with defined genetic composition.
These recombinant mice were derived from 8 parental inbred and
wild-derived strains through an intricate directed breeding pro-
cess (Churchill et al., 2004). Due to the increased genetic diver-
sity of mouse strains that can be interrogated simultaneously,
the Collaborative Cross is expected to provide additional power
to forward genetics screens for many diseases. Together, these
more recent developments are expected to provide greater pre-
dictive power for identification of regulatory intervals underlying
complex multigenic traits.
Prior to the availability of these more sophisticated modern
resources, a seminal study by Dr. Stephen Barthold recognized
that inbred mouse strains exhibit distinct genetic susceptibilities
to Lyme arthritis, recapitulating the range of arthritis severity seen
in patients (Barthold et al., 1990). However, mice do not reca-
pitulate the full depth and breadth of symptoms experienced by
human patients. This is evident in the inability of B. burgdor-
feri to elicit neurological symptoms or erythema migrans in mice
(Garcia-Monco and Benach, 2013). Despite these limitations,
the finding that C3H mice develop severe arthritis and cardi-
tis at reproducible times following intradermal infection with
B. burgdorferi cultured in the laboratory was very important. The
C3H mouse has been used extensively for studies of severe dis-
ease, and the involvement of a variety of cell types and signaling
pathways have been evaluated. Equally important was the obser-
vation that C57BL/6 (B6) mice consistently develop less severe
disease despite being equally susceptible to infection and having
similar numbers of bacteria in joints. Since many mutant alle-
les have been crossed onto the B6 background, this has allowed
identification of the contribution of numerous immunologically
important genes to both host defense and modulation of arthritis
and carditis severity.
Mice and other small mammals are essential reservoir species
for B. burgdorferi in nature, and greater than 90% of trapped wild
mice in some Lyme endemic areas have tested seropositive for
infection (Bunikis et al., 2004; Radolf et al., 2012). Wild mice
are generally resistant to Lyme arthritis, although recent work
has shown that natural variants of known innate immune reg-
ulatory genes may be correlated with the prevalence of Lyme
infection within the wild rodent population (Tschirren et al.,
2013). These considerations make the mouse an excellent model
for assessment of genetic factors contributing to Lyme arthritis
development.
Barthold’s findings were corroborated and expanded upon by
others. Many groups then addressed specific facets of the immune
response and pathogenesis of Lyme arthritis, using the mouse
models developed by Barthold, and that important work contin-
ues today. Many such studies rely on reverse-genetic approaches,
such as targeted genetic deletion, gene silencing, treatment with
inhibitory or stimulatory molecules, or transgenic manipulation.
For example, the importance of the innate immune response
in Lyme pathogenesis was demonstrated by Schaible, Barthold,
and Brown who collectively observed that mice with severe com-
bined immunodeficiency (scid/Rag−), lacking B and T cells,
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retained the differential genetic severities in arthritis and carditis
observed between inbred mouse strains (Schaible et al., 1989;
Barthold et al., 1992; Brown and Reiner, 1999). This finding
set a lasting framework for future studies into various facets
of the innate immune response. The reverse genetic techniques
used in these and other studies are powerful and conclusive,
and have resulted in the identification of many genes with doc-
umented importance in the pathogenesis of Lyme arthritis and
host defense to B. burgdorferi. However, these approaches are by
nature biased to genes with known function and are not suitable
for global analysis of the potential genetic contribution to dis-
ease. Selection of a candidate gene necessarily involves assessment
of pathways that are suspected to influence the disease process,
resulting in the rejection or delay of other non-candidate genes for
study.
BRIEF REVIEW OF GENETIC ASSOCIATIONS WITH HUMAN
LYME DISEASE AND RELATED MOUSE STUDIES
ROLE OF THE MHC IN IMMUNE RESPONSE TO B. BURGDORFERI AND
IN ARTHRITIS SEVERITY: HUMAN AND MOUSE STUDIES
Several important studies have discovered natural genetic alle-
les that influence Lyme arthritis severity. Steere et al. first
reported the influence of the human major histocompatibil-
ity complex (MHC) on Lyme arthritis severity, and provided
important early evidence that Lyme arthritis has an immuno-
genetic basis (Steere et al., 1990). This pioneering work iden-
tified increased incidence of clinical Lyme arthritis, particularly
that lasting longer that 12 months in a single joint, as associ-
ated with two serologically defined Class II alleles, HLA-DR4
and HLA-DR2. Importantly, the association of Class II alle-
les with Lyme arthritis was not supported by studies inclu-
sive of all outcomes of Lyme arthritis patients. The advent of
molecular characterization of Class II alleles allowed more pre-
cise analysis of associations with disease phenotype, and led
to the conclusion that MHC alleles are not major determi-
nants of early Lyme disease severity, a distinction from rheuma-
toid arthritis (Feng et al., 1995; Klempner et al., 2005). More
recently, Steere and colleagues have confirmed the association
of two Class II alleles (DRB1∗0101 and 0401) for the subgroup
of patients with treatment refractory Lyme disease but not in
the larger group of patients that respond to antibiotic treat-
ment, and have proposed an auto-immune mechanism in this
treatment refractory group (Steere et al., 2006; Drouin et al.,
2013).
A number of investigators found association of MHC hap-
lotypes with antibody recognition of individual B. burgdorferi
antigens using MHC congenic mouse lines. However, use of
MHC congenics in our studies and in those of other investiga-
tors led to the conclusion that MHC alleles were not determinants
for the differences in arthritis severity found 4 weeks follow-
ing infection in C3H-H2k, C57BL/6-H2b, and DBA-H2d mice
(Yang et al., 1992; Brown and Reiner, 2000). Thus, studies with
mice are consistent with patient studies failing to show associa-
tion with early Lyme arthritis. Interestingly, mice expressing the
H2k allele do not develop collagen-induced arthritis, a contrast
with their development of severe Lyme arthritis (Wooley et al.,
1981).
IDENTIFICATION OF TLR1/TLR2 IN THE HOST RESPONSE TO
B. BURGDORFERI IN HUMANS AND MICE
Early seminal studies into the host-pathogen interaction of
B. burgdorferi revealed the potential of the spirochete and its
lipoproteins to induce inflammatory cytokine production in a
variety of human and mouse cell types (Radolf et al., 1991;
Wooten et al., 1996; Sellati et al., 1998). The association of
NF-κB with these inflammatory responses directed numerous
laboratories to investigate the involvement of Toll-like receptors
as these molecules were discovered as central components of
inflammatory responses to microbial pathogens (Wooten et al.,
1996; Sellati et al., 1998). These studies documented the interac-
tions between B. burgdorferi lipoproteins with TLR2 and TLR1,
both with mouse knock-out and cell culture transfection studies
and in patients, and established a critical role for TLR signal-
ing through MyD88 in host defense to this pathogen (Aliprantis
et al., 1999; Brightbill et al., 1999; Hirschfeld et al., 1999, 2000;
Alexopoulou et al., 2002). More recent studies by Schroder et al.
identified a human variant in TLR2, Arg753Gln, with reduced
pro-inflammatory signaling in patient samples (Schroder et al.,
2005). Cells from mice heterozygous for this variant also dis-
played reduced inflammatory responses to B. burgdorferi lysate.
Notably, this TLR2 allele was significantly underrepresented
within a cohort of late stage Lyme disease patients, suggesting that
it has a protective effect.
Oosting et al. found that N248S and S602I polymorphisms
in TLR1 were associated with reduced in vitro responsiveness to
B. burgdorferi and TLR1/TLR2 agonist stimulation (Oosting et al.,
2011a). Using a similar experimental approach, the same group
also reported that peripheral blood mononuclear cells (PBMCs)
for individuals bearing an IL-23R Arg381Gln polymorphism
exhibited a reduced Th17 response following in vitro stimulation
with B. burgdorferi (Oosting et al., 2011b). However, there was
no association between the IL-23R polymorphism and the per-
sistence of symptoms among patients in the study population,
arguing against a role for this SNP in disease pathogenesis.
Strle et al. recently described the frequency and impact of sev-
eral polymorphisms in the TLR1 gene within a cohort of Lyme
disease patients (Strle et al., 2012). This study found a skewed
inheritance pattern of TLR1 1805GG polymorphisms within an
antibiotic-refractory Lyme arthritis patient population. They also
recognized a synergy between inheritance of this host polymor-
phism and infection with a particular invasive isolate (termed
RST1) of B. burgdorferi. Importantly, patients carrying TLR1
1805GG exhibited higher serum levels of CXCL9 and CXCL10
chemokines, consistent with a functional role for this polymor-
phism. This effect was reproduced through in vitro activation of
PBMCs with a B. burgdorferi RST1 isolate, arguing that height-
ened production of these IFNγ-inducible chemokines may set the
stage for antibiotic refractory arthritis.
THE POWER OF FORWARD GENETICS
Forward Genetic approaches attempt to determine which genetic
loci are responsible for a phenotype of interest. In general, indi-
viduals are generated with genotypes that have been altered in an
unbiased way, followed by analysis to map inheritance of the phe-
notype of interest to specific genetic loci. This was made possible
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by the development of genetic maps of microsatellite landmarks
evenly distributed throughout the genome, the utility of which
Paterson et al. first demonstrated for Quantitative Trait Locus
(QTL) mapping in plants, later followed by Todd et al. in mice
(Paterson et al., 1988; Todd et al., 1991). Model organisms are
often studied through QTL analysis followed by the breeding of
recombinant inbred congenic lines to isolate regulatory loci, and
the Collaborative Cross is a more expansive modern variation of
this theme that combines these two steps together. QTL map-
ping of disease susceptibility in mice has the potential to yield a
veritable avalanche of information about complementary facets
of disease initiation and pathogenesis. For example, efforts by
Edward Wakeland and others to determine differential suscepti-
bility to systemic lupus erythematosus (sle) between resistant and
acutely lupus-prone inbred mouse strains led to the identification
of Ly108 and other SLAM family members as key modulators
of B cell tolerance (Kumar et al., 2006), lack of proper Fcgr2b
upregulation as a potentiator of IgG production (Rahman et al.,
2007), Cr2 or other closely linked genes as mediators of autore-
active B- and T-cell production (Chen et al., 2005; Tchepeleva
et al., 2010), and hemostatic kallikreins as important regulators
of kidney pathogenesis (Liu et al., 2009).
Other successes include the identification of genes impor-
tant in the regulation of animal models of rheumatoid arthritis
and autoimmunity by comparing disease susceptible and dis-
ease resistant mouse strains (Ma et al., 2002; Glant et al., 2004;
Wicker et al., 2005; Ahlqvist et al., 2009). In some cases, QTL
mapping efforts have bridged gaps between seemingly distinct
experimental models of autoimmune and other inflammatory
diseases through the identification of shared immunopathology
loci (Teuscher, 1985; Meeker et al., 1995; Teuscher et al., 1996,
1997, 1998; Del Rio et al., 2008; Spach et al., 2009, 2010) and iden-
tification of the relevant functional polymorphisms (Sudweeks
et al., 1993; Ma et al., 2002).
The first step of QTL analysis in mice is the direct inter-
breeding of two strains of interest to generate a large cohort of
genetically distinct individuals (Figure 1). F1 hybrids are geneti-
cally identical, carrying one copy of each chromosome from each
parental line. These hybrids can be backcrossed to either parental
strain (BC1), or interbred to generate F2 hybrids. In each case,
genetic variability among the offspring is generated by random
recombination events between sister chromatids during meiosis.
Each interbreeding strategy can identify regulatory alleles with a
dominant, codominant, or additive effect. F2 intercross popula-
tions allow the identification of alleles acting in recessive fashion
that are capable of “standing alone,” whereas the BC1 populations
have the added advantage of allowing identification of genetic
alleles whose effect is most apparent in the genetic context of a
particular inbred background. However, hybrids backcrossed to
a parental strain are not expected to detect any phenotype from
recessive alleles bred back to a dominant parent.
CURRENT PROGRESS: MAPPING QUANTITATIVE TRAIT LOCI
THAT REGULATE LYME ARTHRITIS SEVERITY IN MICE
Janis Weis, Cory Teuscher, and their collaborators performed the
first murine Lyme arthritis QTL analysis (Weis et al., 1999). This
initial study used an F2 intercross between C57BL/6N (B6) and
FIGURE 1 | Forward Genetics approach for Lyme arthritis severity.
Intercross populations of B6 and C3H mice were used for identification of
Quantitative Trait Loci (QTL) regulating Borrelia burgdorferi associated
arthritis and other responses related to infection (Bbaa). Arthritis and other
metrics of host response were assessed at 4 weeks of infection. A total
genome scan was performed for each infected mouse (n = 450) and
threshold permutation analysis identified loci associated with disease and
response.
C3H/HeN (C3H) mice, with 150 total male and female mice
included in the cohort. Each individual was assessed for seven
quantitative traits and for genetic composition, which was deter-
mined using 195 microsatellite markers distributed throughout
the genome. Permutation threshold analysis was then used for the
entire cohort to determine the degree of association between these
quantitative traits and the parental derivation of specific loci.
Four distinct regions on chromosomes 4, 5, and 11 were found
to regulate arthritis severity traits as measured by caliper mea-
surement of ankle swelling and by blinded scoring of a number
of microscopically assessed histopathology traits. Five additional
loci on chromosomes 6, 9, 11, 12, and 17 were found to reg-
ulate B. burgdorferi-specific humoral IgM and IgG responses
independently of arthritis severity.
This foundational study was followed up by Roper et al. with
additional QTL experiments using reciprocal F1 × B6 and F1 ×
C3H backcrosses and a (BALB/c × C3H) F1 × C3H intercross
that found 12 new QTL on Chromosomes 1, 2, 4, 6, 7, 9, 10,
12, 14, 15, 16, and 17 regulating a variety of traits (Roper et al.,
2001). A total of twenty-three QTL were identified that regulate
metrics of arthritis severity (Figure 2, red) or other traits related
to the humoral response, inflammatory response, or host defense
(Figure 2, blue). As predicted from previousMHC congenic stud-
ies, none of the arthritis-associated QTL identified in the three
B6:C3H intercrosses identified the MHC locus on chromosome
17. Interestingly, ankle swelling did associate with this region in
a single backcross (BALB/c × C3H) F1 × BALB/c, with a lod
score of 3.1, predicting an association with one or more of the
numerous class I, class II, or class III genes in this region. Seven of
the 23 QTL were reproduced in multiple crosses (Bbaa2, Bbaa6,
Bbaa8, Bbaa10, Bbaa12, Bbaa14, and Bbaa15). The Bbaa2 QTL
on Chromosome 5 was reproduced in all four intercross exper-
iments, and in every case the arthritis severity originated from
the C3H parental strain. The lod scores identifying Bbaa2 ranged
from 3.5 to 10.2 for the four intercross populations, with the 10.2
Frontiers in Cellular and Infection Microbiology www.frontiersin.org June 2014 | Volume 4 | Article 76 | 4
Bramwell et al. Forward genetics of lyme arthritis
FIGURE 2 | Location of predicted Quantitative Trait Loci, summarized
from Weis et al. (1999) and Roper et al. (2001). Black and gray bands on
each chromosome denote an idealized representation of the Giemsa banding
pattern found in a normal mouse karyotype. Red shaded regions denote QTL
regulating arthritis severity (ankle swelling, histopathology score, tendon
sheath). Blue shaded regions denote QTL regulating humoral immune
response (Total/Specific IgM levels, Total/Specific IgG levels, serum IL-6) or
host defense (B. burgdorferi bacterial burden).
lod value detected in the (BALB/c × C3H) F1 × C3H intercross.
This study also predicted that the combined Bbaa2Bbaa3 locus
contains at least four distinct regulatory genes. It is possible that
some of these loci may be implicated in other QTL studies, but
the use of different inbred strains of mice and the extensive poly-
morphism of this region of the genome among strains confounds
the ability to directly extrapolate between studies (Lindvall et al.,
2009).
Based on these and other data, several subsequent studies
generated congenic mouse strains to isolate putative regulatory
loci in the context of an otherwise uniform genetic background.
This laborious and time-intensive process is essential to convert
the statistically predicted loci derived from QTL analysis into
physical genetic boundaries. Congenic lines can also be used to
formally interrogate potential candidate genes, by determining
if the phenotype of interest is retained after such a candidate
gene is excluded from the congenic interval. The presence of
a strongly penetrant phenotype within a congenic interval is a
strong predictor of success in further steps of positional cloning.
Subsequent studies used congenic mice based on the initial
QTL assignments. Crandall et al. described the phenotype of two
B6 × C3H congenic lines, and the evaluation of a specific can-
didate gene (Crandall et al., 2005). B6 × C3H F1 mice were
backcrossed seven times onto each parental background, produc-
ing reciprocal congenic lines B6.C3H-Bbaa2Bbaa3 and C3H.B6-
Bbaa2Bbaa3. Of note, the congenic nomenclature in mice differs
from other systems, with the background strain listed first, fol-
lowed by the donor strain, followed by the introgressed locus
(Jackson Laboratory, 2000). Bbaa2Bbaa3 from the C3H donor
strain was found to confer increased Lyme arthritis severity on a
resistant B6 background, while B6 derived Bbaa2Bbaa3 conferred
reduced severity to susceptible C3H mice, in a reciprocal fashion.
This publication also described a polymorphism carried by C3H
mice in the Ncf1 gene, but ruled out this candidate with a variety
of studies, including the finding that B6 Ncf1−/− mice exhibited
no increase in arthritis severity relative to wild type B6 controls.
Ma et al. reported the generation of additional B6xC3H recip-
rocal congenic lines for five intervals identified in the foun-
dational QTL study (Bbaa1, Bbaa2Bbaa3, Bbaa4, and Bbaa6),
plus another pair of reciprocal congenic lines for an interval on
Chromosome 1 (Bbaa12) (Ma et al., 2009). Through marker-
assisted selection over the course of seven iterative backcrosses,
these intervals were isolated and found to be free of genetic
contamination on other chromosomes, with congenic intervals
ranging from 25 to 146 megabases in size. Bbaa2Bbaa3 and
Bbaa4 were found to reciprocally transfer the ankle swelling and
histopathology phenotypes, while the B6 allele of Bbaa6 trans-
ferred protection from ankle swelling and histopathology to the
C3H background. Other congenic intervals conferred no change
in arthritis severity or gave inconsistent results. This study also
demonstrated the added utility of congenic lines as an experi-
mental resource through comparative microarray gene expression
profiling.
In the process of further refining these congenic intervals,
Bramwell et al. described the implementation of high throughput
SNP genotyping and high resolution melting analysis (Bramwell
et al., 2012). This improved genotypingmethodology took advan-
tage of the recently published Sanger high-resolution sequence of
the C3H mouse, allowing enhanced comparison with the previ-
ously published genome of the B6 reference strain (Keane et al.,
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2011). The Sanger database revealed the precise location of thou-
sands of SNPs distinguishing B6 and C3H genomic sequences
within the 20Mbp Bbaa2 interval, exponentially increasing the
ability to discriminate donor sequences and define boundaries
of congenic mice, and allowing the genetic composition of the
congenic lines to be tested with greater precision (Figure 3). As
an added benefit, the screening process was accelerated, help-
ing to reduce expenses by allowing litters to be screened prior to
weaning age.
This line of investigation has recently culminated in the iden-
tification of the first definitive natural regulator of Lyme arthritis
severity in laboratory mice. With further backcrossing and refine-
ment of the B6.C3H-Bbaa2 congenics, Bramwell et al. describe the
generation of 14 new advanced congenics that delimit the bound-
aries of several regulatory sub-intervals (Figure 4) (Bramwell
et al., 2014). Notably, these intervals bear striking resemblance
to several of the maximal linkage peaks predicted previously
(Roper et al., 2001). One narrow 1.5Mb C3H-derived interval,
surrounding and including the highest peak of linkage predicted
by QTL analysis at D5Mit30 on Chromosome 5, was able to
independently confer an increased arthritis severity phenotype in
the context of a resistant B6 genetic background. Close scrutiny
of this interval revealed only a single coding-non-synonymous
polymorphism between B6 and C3H mice. This point mutation
in the lysosomal enzyme beta-Glucuronidase leads to a par-
tially hypomorphic allele (Gusbh) in the C3H, AKR, and CBA/J
inbred strains. Peromyscus mice, which do not exhibit Lyme
arthritis but serve as important reservoir hosts for B. burgdor-
feri in nature, appear to carry the wild-type B6 allele of Gusb
(GenBank Accession XM_006971357). The exacerbated Lyme
arthritis effect conferred by Gusbh was recapitulated in a spon-
taneous Gusb mutant mouse line (GusbNull), and transgenic
overexpression of wild type Gusbb in C3H mice (GusbTg) pro-
foundly reduced ankle swelling and histopathology. The Gusbh
congenic line was further tested in an experimental model of RA,
FIGURE 3 | A SNP genotyping methodology improves congenic
mapping precision, adapted from Bramwell et al. (2012). ∗ - Location of
all 11 microsatellite markers that can differentiate between B6 and C3H
DNA across Bbaa2. # - Of the thousands of SNPs available (blue line), the
28 positions that were developed into SNP genotyping assays for improved
discrimination of sub-interval congenic lines (Bramwell et al., 2014).
the K/BxN serum transfer model (Monach et al., 2008). Disease
severity in this model is induced by autoantibodies generated
against glucose-6-phosphate isomerase, a ubiquitous glycolytic
enzyme. Importantly, transfer of this serum induces a joint spe-
cific inflammatory arthritis that occurs independently of the
MHC haplotype of the recipient and reflects the effector phase
of arthritis development. Much greater arthritis severity was
observed in Gusbh congenic mice than in wild type B6 control
animals, revealing a common mechanism for the pathogenesis of
Lyme arthritis and rheumatoid arthritis. Thus, the identification
of genes important in Lyme arthritis also illuminated previously
unrecognized pathways in RA. This linkage to a gene associ-
ated with Sly syndrome, an overt congenital lysosomal storage
disease (LSD), strongly implicated a common pathogenic mech-
anism involving accumulation of undigested glycosaminoglycans
(Tomatsu et al., 2009). This possibility was confirmed by detec-
tion of pronounced Alcian blue staining of sulfated GAGs in the
inflamed joint tissues of B. burgdorferi infected and K/BxN treated
mice with partial or severe Gusb deficiencies (Figure 5). The
association ofGusbh with increased disease severity in both Lyme-
associated and rheumatoid arthritis identifies Gusb as a shared
immunopathology disease gene (Teuscher, 1985; Sudweeks et al.,
1993; Ma et al., 2002).
The novelty of the beta-Glucuronidase polymorphism high-
lights the power and added value of forward genetic approaches.
Gusb is most often cited in the recent scientific literature as a
housekeeping gene, primarily used as a reference to study some-
thing more interesting, making it a most unlikely candidate for
a hypothesis-driven reverse genetics study. Allelic variants of the
Gusb gene were found not to be differentially expressed under
FIGURE 4 | Regulatory loci identified by analysis of advanced congenic
lines, modified from Bramwell et al. (2014). (A) Each of the top 8
horizontal bars represents one B6.C3H-Bbaa2 sub-interval congenic mouse
line. The horizontal axis represents the position of Bbaa2 on mouse
Chromosome 5 (120.3–141.2Mb). The black portions of each row are
derived from the C3H genetic background and the white portions are
derived from the B6 background. Colored boxes indicate the position
boundaries and predicted effect (+/−) of multiple regulatory intervals
identified by advanced congenic lines. The lower 4 rows indicate arthritis
severity QTL intervals predicted by Roper et al. (2001) for the
backcross/intercross populations listed on the left vertical axis. Horizontal
hatching denotes QTL for ankle swelling, vertical hatching denotes QTL for
histopathology or tendon sheath thickening, cross hatching denotes overlap
of multiple predicted QTL. (B) Ankle swelling measurements for the eight
congenic lines listed in A, with significance assessed relative to B6
negative control. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗∗P < 0.0001.
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FIGURE 5 | Alcian blue staining reveals excess deposition of GAGs
within severely arthritic ankle joints, modified from Bramwell et al.
(2014). Top left panel: Ankle joint section from a day 7 K/BxN treated B6
mouse at ×4 magnification. Remaining panels: Ankle joint section from a
day 7 K/BxN treated B6.C3H-Gusbh mouse. Original magnification ×4, ×20,
and ×40. Scale bars: 500, 100, 50μm, respectively. Boxes on the top right
and lower left images indicate the location of the field magnified in
subsequent images.
baseline conditions, and no changes in Gusb expression were
detected by microarray analysis of joint tissue from naïve and
infected C3H and B6 mice (Crandall et al., 2006; Bramwell et al.,
2014). Thus, Gusb and other similar genes associated with LSD
are not likely to be picked up by a microarray or RNA-Seq study
in Lyme arthritis patients. Gusb was also not included in the
ImmunoChip used in human RA and juvenile RA studies, because
it had not yet been identified as a potential regulator (Eyre et al.,
2012; Hinks et al., 2013). As mentioned earlier, recent devel-
opment of an expanded group of recombinant inbred strains
incorporating 8 strains of laboratory and wild mice would appear
to be a powerful resource for investigating regulators of Lyme
arthritis severity. However, none of the three inbred strains carry-
ing the Gusbh polymorphism were included in the Collaborative
Cross, so it could not have been identified through this approach.
Against all odds, the identification of Gusb is a prime example
of how relentlessly following the phenotype throughout a process
of unbiased genetic refinement can overcome preconception and
bias to lead the way to truly novel and unexpected discoveries.
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